Role of hypertonic saline for the management of intracranial hypertension after stroke and traumatic brain injury

Pharmacotherapy

Volumn 28, Issue 4, 2008, Pages 469-484

  Forsyth, Lisa L ^a   Liu DeRyke, Xi ^b   Parker Jr , Dennis ^c,d   Rhoney, Denise H ^c,d  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d DETROIT RECEIVING HOSPITAL   (United States)

Author keywords

Hypertonic saline; Intracranial hypertension; Neurologic injury; Osmotherapy

Indexed keywords

MANNITOL; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; ANEMIA; BLOOD CLOTTING DISORDER; BRAIN EDEMA; BRAIN HEMORRHAGE; CENTRAL PONTINE MYELINOLYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG MONITORING; DRUG SAFETY; EDEMA; ELECTROLYTE DISTURBANCE; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPERNATREMIA; HYPERVOLEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; INFECTION; INFLAMMATION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MEDICAL EDUCATION; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; OSMOLARITY; OSMOSIS; PEDIATRICS; PHLEBITIS; PROTHROMBIN TIME; REVIEW; SIDE EFFECT; STROKE; SUBARACHNOID HEMORRHAGE; THROMBOCYTE AGGREGATION; THROMBOPLASTIN TIME; TISSUE NECROSIS; TRAUMATIC BRAIN INJURY;

BRAIN INJURIES; CLINICAL TRIALS AS TOPIC; HUMANS; INTRACRANIAL HYPERTENSION; OSMOSIS; PHARMACISTS; PROFESSIONAL ROLE; SALINE SOLUTION, HYPERTONIC; STROKE;

EID: 41549092768     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.4.469     Document Type: Review

References (94)

1. Ogden AT, Mayer SA, Connolly ES Jr. Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery 2005;57:207-15.
2. Bingaman WE, Frank JI. Malignant cerebral edema and intracranial hypertension. Neurol Clin 1995;13:479-509.
3. Avezaat CJ, van Eijndhoven JH, Wyper DJ. Cerebrospinal fluid pulse pressure and intracranial volume-pressure relationships. J Neurol Neurosurg Psychiatry 1979;42:687-700.
4. Bouma GJ, Muizelaar JP, Bandoh K, Marmarou A. Blood pressure and intracranial pressure-volume dynamics in severe head injury: relationship with CBF J Neurosurg 1992;77:15-19.
5. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. Guidelines for the management of severe traumatic brain injury. VII. Intracranial pressure thresholds. J Neurotrauma 2007;24(suppl 1):S55-8.
6. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma 2007;24(suppl 1):S59-64.
7. Juul N, Morris GF, Marshall SB, Marshall LF, for the Executive Committee of the International Selfotel Trial. Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. J Neurosurg 2000;92:1-6.
8. Robertson CS. Management of cerebral perfusion pressure after traumatic brain injury. Anesthesiology 2001;95:1513-17.
9. Robertson CS, Valadka AB, Hannay HJ, et al. Prevention of secondary ischemic insults after severe head injury. Crit Care Med 1999;27:2086-95.
10. Marmarou A. A review of progress in understanding the pathophysiology and treatment of brain edema [online exclusive article]. Neurosurg Focus 2007;22:E1. Available from http://www.aans.org/education/ journal/neurosurgical/May07/22-5-1-1146.pdf.
11. Unterberg AW, Stover J, Kress B, Kiening KL. Edema and brain trauma. Neuroscience 2004;129:1021-9.
12. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. Critical pathway for the treatment of established intracranial hypertension. J Neurotrauma 2000;17:537-8.
13. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neurotrauma 2007;24(suppl 1):S14-20.
14. Bhardwaj A, Ulatowski JA. Hypertonic saline solutions in brain injury. Curr Opin Crit Care 2004;10:126-31.
15. Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993;34:216-22.
16. Clifton GL, Miller ER, Choi SC, Levin HS. Fluid thresholds and outcome from severe brain injury. Crit Care Med 2002;30:739-45.
17. Zornow MH. Hypertonic saline as a safe and efficacious treatment of intracranial hypertension. J Neurosurg Anesthesiol 1996;8:175-7.
18. Kramer GC. Hypertonic resuscitation: physiologic mechanisms and recommendations for trauma care. J Trauma 2003;54(suppl):S89-99.
19. Oliveira RP, Velasco I, Soriano F, Friedman G. Clinical review: hypertonic saline resuscitation in sepsis. Crit Care 2002;6:418-23.
20. Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000;28:3301-13.
21. Doyle JA, Davis DP, Hoyt DB. The use of hypertonic saline in the treatment of traumatic brain injury. J Trauma 2001;50:367-83.
22. Lenzlinger PM, Hans VH, Joller-Jemelka HI, Trentz O, Morganti-Kossmann MC, Kossmann T. Markers for cell-mediated immune response are elevated in cerebrospinal fluid and serum after severe traumatic brain injury in humans. J Neurotrauma 2001;18:479-89.
23. Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol 1998;161:6288-96.
24. Rhee P, Wang D, Ruff P, et al. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 2000;28:74-8.
25. Loomis WH, Namiki S, Hoyt DB, Junger WG. Hypertonicity rescues T cells from suppression by trauma-induced anti-inflammatory mediators. Am J Physiol Cell Physiol 2001;281:C840-8.
26. Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV. Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J Immunol 2002;168:1389-96.
27. Junger WG, Coimbra R, Liu FC, et al. Hypertonic saline resuscitation: a tool to modulate immune function in trauma patients? Shock 1997;8:235-41.
28. 2)-induced T-cell suppression. Shock 1995;4:45-9.
29. 2 and interleukin-4 production. J Surg Res 1996;64:203-9.
30. Gushchin V, Stegalkina S, Alam HB, Kirkpatrick JR, Rhee PM, Koustova E. Cytokine expression profiling in human leukocytes after exposure to hypertonic and isotonic fluids. J Trauma 2002;52:867-71.
31. Botha AJ, Moore FA, Moore EE, Sauaia A, Banerjee A, Peterson VM. Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma 1995;39:411-17.
32. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 1995;75:257-77.
33. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA. Post-injury multiple organ failure: the role of the gut. Shock 2001;15:1-10.
34. Van Putte BP, Kesecioglu J, Hendriks JM, et al. Cellular infiltrates and injury evaluation in a rat model of warm pulmonary ischemia-reperfusion. Crit Care 2005;9:R1-8.
35. Attuwaybi B, Kozar RA, Gates KS, et al. Hypertonic saline prevents inflammation, injury, and impaired intestinal transit after gut ischemia/reperfusion by inducing heme oxygenase 1 enzyme. J Trauma 2004;56:749-59.
36. Powers KA, Zurawska J, Szaszi K, Khadaroo RG, Kapus A, Rotstein OD. Hypertonic resuscitation of hemorrhagic shock prevents alveolar macrophage activation by preventing systemic oxidative stress due to gut ischemia/reperfusion. Surgery 2005;137:66-74.
37. Shields CJ, Winter DC, Manning BJ, Wang JH, Kirwan WO, Redmond HP. Hypertonic saline infusion for pulmonary injury due to ischemia-reperfusion. Arch Surg 2003;138:9-14.
38. Gurfinkel V, Poggetti RS, Fontes B, da Costa Ferreira Novo F, Birolini D. Hypertonic saline improves tissue oxygenation and reduces systemic and pulmonary inflammatory response caused by hemorrhagic shock. J Trauma 2003;54:1137-45.
39. Hartl R, Medary MB, Ruge M, Arfors KE, Ghahremani F, Ghajar J. Hypertonic/hyperoncotic saline attenuates microcirculatory disturbances after traumatic brain injury. J Trauma 1997;42(suppl):S41-7.
40. Kolsen-Petersen JA, Nielsen JO, Bendtzen K, Tonnesen E. Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiol Scand 2004;48:224-33.
41. Kolsen-Petersen JA, Nielsen JO, Tonnesen EM. Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology 2004;100:1108-18.
42. Angle N, Cabello-Passini R, Hoyt DB, et al. Hypertonic saline infusion: can it regulate human neutrophil function? Shock 2000;14:503-8.
43. Bulger EM, Cuschieri J, Warner K, Maier RV. Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Ann Surg 2007;245:635-41.
44. Weed LH, McKibben PS. Pressure changes in the CSF following intravenous injection of solutions of various concentration. Am J Physiol 1919;48:512-30.
45. Mattox KL, Maningas PA, Moore EE, et al. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The USA multicenter trial. Ann Surg 1991;213:482-91.
46. Shackford SR, Bourguignon PR, Wald SL, Rogers FB, Osler TM, Clark DE. Hypertonic saline resuscitation of patients with head injury: a prospective, randomized clinical trial. J Trauma 1998;44:50-8.
47. Wade CE, Grady JJ, Kramer GC, Younes RN, Gehlsen K, Holcroft JW. Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension. J Trauma 1997;42(suppl):S61-5.
48. Cooper DJ, Myles PS, McDermott FT, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 2004;291:1350-7.
49. Suarez JI, Qureshi AI, Parekh PD, et al. Administration of hypertonic (3%) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg Anesthesiol 1999;11:178-84.
50. Tseng MY, Al-Rawi PG, Pickard JD, Rasulo FA, Kirkpatrick PJ. Effect of hypertonic saline on CBF in poor-grade patients with subarachnoid hemorrhage. Stroke 2003;34:1389-96.
51. Bentsen G, Breivik H, Lundar T, Stubhaug A. Predictable reduction of intracranial hypertension with hypertonic saline hydroxyethyl starch: a prospective clinical trial in critically ill patients with subarachnoid haemorrhage. Acta Anaesthesiol Scand 2004;48:1089-95.
52. Bentsen G, Breivik H, Lundar T, Stubhaug A. Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit Care Med 2006;34:2912-17.
53. Qureshi AI, Suarez JI, Bhardwaj A. Malignant cerebral edema in patients with hypertensive intracerebral hemorrhage associated with hypertonic saline infusion: a rebound phenomenon? J Neurosurg Anesthesiol 1998;10:188-92.
54. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002;33:136-40.
55. Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998;29:1550-5.
56. Bhardwaj A, Harukuni I, Murphy SJ, et al. Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke 2000;31:1694-701.
57. Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005;33:196-202; discussion 57-8.
58. Berger S, Schwarz M, Huth R. Hypertonic saline solution and decompressive craniectomy for treatment of intracranial hypertension in pediatric severe traumatic brain injury. J Trauma 2002;53:558-63.
59. Einhaus SL, Croce MA, Watridge CB, Lowery R, Fabian TC. The use of hypertonic saline for the treatment of increased intracranial pressure. J Tenn Med Assoc 1996;89:81-2.
60. Fisher B, Thomas D, Peterson B. Hypertonic saline lowers raised intracranial pressure in children after head trauma. J Neurosurg Anesthesiol 1992;4:4-10.
61. Hartl R, Ghajar J, Hochleuthner H, Mauritz W. Treatment of refractory intracranial hypertension in severe traumatic brain injury with repetitive hypertonic/hyperoncotic infusions. Zentralbl Chir 1997;122:181-5.
62. Huang SJ, Chang L, Han YY, Lee YC, Tu YK. Efficacy and safety of hypertonic saline solutions in the treatment of severe head injury. Surg Neurol 2006;65:539-46.
63. Khanna S, Davis D, Peterson B, et al. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med 2000;28:1144-51.
64. Lescot T, Degos V, Zouaoui A, Preteux F, Coriat P, Puybasset L. Opposed effects of hypertonic saline on contusions and noncontused brain tissue in patients with severe traumatic brain injury. Crit Care Med 2006;34:3029-33.
65. Munar F, Ferrer AM, de Nadal M, et al. Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure. J Neurotrauma 2000;17:41-51.
66. Peterson B, Khanna S, Fisher B, Marshall L. Prolonged hypernatremia controls elevated intracranial pressure in head-injured pediatric patients. Crit Care Med 2000;28:1136-43.
67. Qureshi AI, Suarez JI, Castro A, Bhardwaj A. Use of hypertonic saline/acetate infusion in treatment of cerebral edema in patients with head trauma: experience at a single center. J Trauma 1999;47:659-65.
68. Saltarini M, Massarutti D, Baldassarre M, Nardi G, De Colle C, Fabris G. Determination of cerebral water content by magnetic resonance imaging after small volume infusion of 18% hypertonic saline solution in a patient with refractory intracranial hypertension. Eur J Emerg Med 2002;9:262-5.
69. Schatzmann C, Heissler HE, Konig K, et al. Treatment of elevated intracranial pressure by infusions of 10% saline in severely head injured patients. Acta Neurochir (Wien) 1998;71:31-3.
70. Simma B, Burger R, Falk M, Sacher P, Fanconi S. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer's solution versus hypertonic saline. Crit Care Med 1998;26:1265-70.
71. Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003;31:1683-7.
72. Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley GT. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery 2005;57:727-36.
73. De Vivo P, Del Gaudio A, Ciritella P, Puopolo M, Chiarotti F, Mastronardi E. Hypertonic saline solution: a safe alternative to mannitol 18% in neurosurgery. Minerva Anesthesiol 2001;67:603-11.
74. Gemma M, Cozzi S, Tommasino C, et al. 7.5% hypertonic saline versus 20% mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesthesiol 1997;9:329-34.
75. Harutjunyan L, Holz C, Rieger A, Menzel M, Grond S, Soukup J. Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients: a randomized clinical trial (ISRCTN62699180). Crit Care 2005;9:R530-40.
76. Horn P, Munch E, Vajkoczy P, et al. Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res 1999;21:758-64.
77. Larive LL, Rhoney DH, Parker D Jr, Coplin WM, Carhuapoma JR. Introducing hypertonic saline for cerebral edema: an academic center experience. Neurocrit Care 2004;1:435-40.
78. Qureshi AI, Suarez JI, Bhardwaj A, et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med 1998;26:440-6.
79. Suarez JI, Qureshi AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998;26:1118-22.
80. Adelson PD, Bratton SL, Carney NA, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents: use of hyperosmolar therapy in the management of severe pediatric traumatic brain injury. Pediatr Crit Care Med 2003;4(3 suppl):S40-4.
81. Kalita J, Ranjan P, Misra UK. Current status of osmotherapy in intracerebral hemorrhage. Neurol India 2003;51:104-9.
82. Nau R. Osmotherapy for elevated intracranial pressure: a critical reappraisal. Clin Pharmacokinet 2000;38:23-40.
83. Toung TJ, Hurn PD, Traystman RJ, Bhardwaj A. Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline. Crit Care Med 2002;30:644-9.
84. Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 1986;314:1535-42.
85. Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med 1997;126:57-62.
86. Paczynski RP. Osmotherapy: basic concepts and controversies. Crit Care Clin 1997;13:105-29.
87. Shackford SR, Fortlage DA, Peters RM, Hollingsworth-Fridlund P, Sise MJ. Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surg Gynecol Obstet 1987;164:127-36.
88. Vassar MJ, Perry CA, Gannaway WL, Holcroft JW. 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Arch Surg 1991;126:1065-72.
89. Huang PP, Stucky FS, Dimick AR, Treat RC, Bessey PQ, Rue LW. Hypertonic sodium resuscitation is associated with renal failure and death. Ann Surg 1995;221:543-57.
90. Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit Care 2004;1:219-33.
91. Reed RL II, Johnston TD, Chen Y, Fischer RP. Hypertonic saline alters plasma clotting times and platelet aggregation. J Trauma 1991;31:8-14.
92. Bhardwaj A, Ulatowski JA. Cerebral edema: hypertonic saline solutions. Curr Treat Options Neurol 1999;1:179-88.
93. The Joint Commission. National patient safety goals. Available from www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals/ 07_hap_cah_npsgs.htm. Accessed April, 13, 2007.
94. Cohen MR, Kilo CM. Medication errors. Washington, DC: American Pharmaceutical Association; 1999.